Since the July 2019 voluntary recall of textured breast implant Biocell, pharmaceutical company Allergan has been under fire. The recall came after research linked the implant with cases of breast implant associated anaplastic large cell lymphoma (BIA-ALCL). Allergan plans to launch a tracking campaign for U.S. breast implant patients in the near … [Read more...]
Advances Made in Understanding and Treatment of BIA-ALCL
Since our previous article regarding the connection between textured breast implants and Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL), additional information on understanding the disease and its treatment has surfaced. Background on BIA-ALCL and Recent Legislation While the cause of BIA-ALCL was initially believed … [Read more...]
Cancer Linked to Breast Implants: Is it Considered Rare Anymore?
As you may know from our previous articles, specific kinds of textured breast implants have been banned and recalled in countries due to their link to a cancer called Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). France, Canada, and Australia have banned Allergan’s textured breast implants and the U.S. FDA has recalled them. … [Read more...]
FDA Proposes New Recommendations for Breast Implant Labels
The FDA has come up with a draft guidance list of labeling changes that they recommend be made by breast implant manufacturers to address the safety concerns threatening women all over the world. The recent October 2019 article from The New York Times, “Women Should Be Warned of Breast Implant Hazards, F.D.A. Says”, tells us that “Agency officials … [Read more...]
TGA Regulations on Breast Implant Products
Implants in Australia Back in July, health officials in Australia recommended the ban of textured implants. Our previous July 2019 article, "Textured Breast Implants Ban: Onto Australia", discussed the type of implants up for suspension by Australia's Therapeutic Goods Administration (TGA). Now in Australia, textured breast implants being … [Read more...]
Statistics Show An Increased Risk For BIA-ALCL With Textured Implants
Issue of BIA-ALCL and Textured Implants Several of our previous articles have discussed the connection between textured breast implants and Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). France, Canada, Australia, and other countries have taken steps to ban or have already banned certain textured implants. You can refer to … [Read more...]
Textured Breast Implants Ban: Onto Australia
As we have continued to monitor the situation of breast implants and their risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL), textured implants have seemed to stay at the forefront of the issue. We know that several countries outside of the United States have banned this type of implant due to the conclusion that the risk … [Read more...]
When Might The FDA Ban Textured Implants In The US?
As of the May 2019 the FDA has decided not to ban textured implants in the U.S. due to the lack of a strong causal relationship between this particular type of implant and Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). In contrast, Canada has the sales of textured implants are being put to a halt. In late May 2019 this … [Read more...]
FDA Fails When It Comes To Banning Textured Breast Implants
The U.S. will not be following in the footsteps of Canada and France as regards banning textured breast implants, at least as of May 2019. The New York Times provided us with an article on May 2, 2019, “F.D.A. Won’t Ban Sales of Textured Breast Implants Linked to Cancer” which informs us that while most BIA-ALCL cases have occurred in relation … [Read more...]
Textured Breast Implants Bans on the Rise
An NBC News article, “French authorities call for ban of Allergan textured breast implants” provides us with recent data on this issue. The number of BIA-ALCL diagnoses has gone from one per million to one per 2,832. The total number of cases now is 457 in the U.S. and approximately 700 worldwide. The number of deaths has risen from 9 to 16. The … [Read more...]